{"podcast":{"title":"Raleigh News Today | 2 Min News | The Daily News Now!","slug":"raleigh-news-today-2-min-news-the-daily-news-now-7564076","podcast_index_feed_id":7564076,"rss_url":"https://feeds.fastcast.ai/the-raleigh-daily-news-now.xml","website_url":"https://thednn.ai/","image_url":"https://image.fastcast.ai/podcasts/the-raleigh-daily-news-now.jpg","author":"The Daily News Now!","episode_count":2367,"summary":"Hosted by Corey with the Story, Raleigh News Today delivers daily coverage of everything happening in Raleigh with fast, focused updates on local news, government, business, public safety, weather, and the stories shaping the city. From economic growth to community developments, the show keeps you informed on what matters most across Raleigh. Each short episode highlights what matters most—including key updates, local trends, and stories shaping the city—produced by AI for speed, consistency, and clarity. Part of The Daily News Now network, Raleigh News Today is built for listeners who want reliable local news coverage in a quick, easy-to-digest format. Advertise on DNN: advertise@thednn.ai","last_synced_at":"2026-07-27T08:18:44.566641+00:00","page_url":"https://stenobird.com/podcast/raleigh-news-today-2-min-news-the-daily-news-now-7564076"},"episode":{"title":"Lilly Offloads Verzenios in China | Raleigh News","slug":"lilly-offloads-verzenios-in-china-raleigh-news","published_at":"2026-07-05T22:47:15+00:00","page_url":"https://stenobird.com/podcast/raleigh-news-today-2-min-news-the-daily-news-now-7564076/lilly-offloads-verzenios-in-china-raleigh-news","show_page_url":"https://stenobird.com/podcast/raleigh-news-today-2-min-news-the-daily-news-now-7564076","url":"https://api.fastcast.ai/audio/556a647c-30c9-4a27-aca4-4f4b41e31366.mp3","audio_url":"https://api.fastcast.ai/audio/556a647c-30c9-4a27-aca4-4f4b41e31366.mp3","summary":"Eli Lilly is quietly reshaping its China strategy by handing over commercial control of its breast cancer drug Verzenios to Innovent Biologics, while keeping manufacturing and R&D in-house — a move that lets Lilly cash in on China’s big reimbursement list while dodging political heat and generic competition. With Verzenios protected until 2029 and Lilly’s focus squarely on blockbuster weight-loss drugs like Zepbound and Mounjaro, this partnership is less about massive revenue shifts and more about smart operational streamlining — positioning Lilly to win the future without getting bogged down in today’s regulatory and market noise. Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn Advertise on DNN: advertise@thednn.ai This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai. View sources & latest updates: https://sources.thednn.ai/b9ae96a7037af87a","meta_description":"Eli Lilly is quietly reshaping its China strategy by handing over commercial control of its breast cancer drug Verzenios to Innovent Biologics, while keep…","key_points":[],"chapters":[],"topics":[],"duration_seconds":133,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/raleigh-news-today-2-min-news-the-daily-news-now-7564076/episodes/lilly-offloads-verzenios-in-china-raleigh-news/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/raleigh-news-today-2-min-news-the-daily-news-now-7564076/lilly-offloads-verzenios-in-china-raleigh-news.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}